Jim Simons Biond Vax Pharmaceuticals Ltd. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.96 - $1.26 $96 - $126	100 Added 0.55%	18,400 $13,000
Q2 2022 Aug 12, 2022	BUY	$1.16 - $1.88 $21,228 - $34,404	18,300 New	18,300 $21,000
Q3 2021 Nov 12, 2021	SELL	$2.15 - $3.44 $193,719 - $309,950	-90,102 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.6 - $3.91 $234,265 - $352,298	90,102 New	90,102 $259,000
Q3 2020 Nov 13, 2020	SELL	$23.7 - $51.1 $1.28 Million - $2.75 Million	-53,800 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.2 - $24.87 $234,720 - $810,762	32,600 Added 153.77%	53,800 $1.22 Million
Q1 2020 May 14, 2020	BUY	$5.36 - $11.65 $36,984 - $80,385	6,900 Added 48.25%	21,200 $163,000
Q4 2019 Feb 13, 2020	BUY	$5.38 - $9.29 $76,934 - $132,847	14,300 New	14,300 $133,000

Ticker BVXV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,678,800
Market Cap $12M
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.